Status:

UNKNOWN

Intestinal Flora and Metabonomics of Appendicitis

Lead Sponsor:

HongyiQu

Conditions:

Appendicitis

Intestinal Metaplasia

Eligibility:

All Genders

1-14 years

Brief Summary

The goal of this observational study is to learn about the key bacterial flora and metabolites associated with appendicitis in children. The main questions it aims to answer are: * To screen out the ...

Detailed Description

Participants will detect feces using 16s ribosomal RiboNucleicAcid (16S rRNA) gene sequencing technology and differences of the fecal metabolites between healthy children and appendicitis children wer...

Eligibility Criteria

Inclusion

  • Children aged 1-14 years who were initially diagnosed with appendicitis and underwent laparoscopic appendectomy
  • Children aged 1-14 years with non-digestive tract disease and no history of digestive tract disease

Exclusion

  • A family history of intestinal disease
  • Allergic to antibiotic therapy drugs
  • Patients with long-term drug use causing microbial structure changes or intestinal flora disorders
  • Patients with other congenital diseases such as Meckel's diverticulum, intestinal rotation and other malrotation
  • With other systemic diseases, such as obvious upper respiratory tract infection or myocarditis
  • Children with other digestive system diseases after auxiliary examination or surgical diagnosis

Key Trial Info

Start Date :

April 3 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

July 1 2025

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT06035029

Start Date

April 3 2023

End Date

July 1 2025

Last Update

September 13 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The First Affiliated Hospital Of Shandong First Medcial Unversity

Jinan, Shandong, China, 0531